OptiNose, Oslo, Norway.
Drug Deliv Transl Res. 2013 Feb;3(1):42-62. doi: 10.1007/s13346-012-0108-9. Epub 2012 Oct 18.
Nasal delivery is the logical choice for topical treatment of local diseases in the nose and paranasal sinuses such as allergic and non-allergic rhinitis and sinusitis. The nose is also considered an attractive route for needle-free vaccination and for systemic drug delivery, especially when rapid absorption and effect are desired. In addition, nasal delivery may help address issues related to poor bioavailability, slow absorption, drug degradation, and adverse events in the gastrointestinal tract and avoids the first-pass metabolism in the liver. However, when considering nasal delivery devices and mechanisms, it is important to keep in mind that the prime purpose of the nasal airway is to protect the delicate lungs from hazardous exposures, not to serve as a delivery route for drugs and vaccines. The narrow nasal valve and the complex convoluted nasal geometry with its dynamic cyclic physiological changes provide efficient filtration and conditioning of the inspired air, enhance olfaction, and optimize gas exchange and fluid retention during exhalation. However, the potential hurdles these functional features impose on efficient nasal drug delivery are often ignored. With this background, the advantages and limitations of existing and emerging nasal delivery devices and dispersion technologies are reviewed with focus on their clinical performance. The role and limitations of the in vitro testing in the FDA guidance for nasal spray pumps and pressurized aerosols (pressurized metered-dose inhalers) with local action are discussed. Moreover, the predictive value and clinical utility of nasal cast studies and computer simulations of nasal airflow and deposition with computer fluid dynamics software are briefly discussed. New and emerging delivery technologies and devices with emphasis on Bi-Directional™ delivery, a novel concept for nasal delivery that can be adapted to a variety of dispersion technologies, are described in more depth.
鼻腔给药是治疗鼻部和鼻旁窦局部疾病(如变应性和非变应性鼻炎和鼻窦炎)的首选局部治疗方法。鼻腔也被认为是无针接种和全身药物递送的有吸引力的途径,尤其是当需要快速吸收和起效时。此外,鼻腔给药可能有助于解决与生物利用度低、吸收缓慢、药物降解以及胃肠道不良事件相关的问题,并避免肝脏的首过代谢。然而,在考虑鼻腔给药装置和机制时,重要的是要记住,鼻腔气道的主要目的是保护娇嫩的肺部免受有害物质的暴露,而不是作为药物和疫苗的递送途径。狭窄的鼻阀和复杂的卷曲鼻腔几何形状及其动态循环生理变化提供了高效的空气过滤和调节,增强了嗅觉,并在呼气时优化了气体交换和液体保留。然而,这些功能特征对高效鼻腔药物递送构成的潜在障碍往往被忽视。在此背景下,本文综述了现有和新兴的鼻腔给药装置和分散技术的优缺点及其临床性能,重点讨论了它们的临床性能。讨论了局部作用的鼻喷雾泵和加压气雾剂(加压定量吸入器)的 FDA 指导意见中体外测试的作用和局限性。此外,简要讨论了鼻腔铸型研究和鼻腔气流及沉积的计算机模拟与计算流体动力学软件的预测价值和临床实用性。本文还更深入地描述了具有双向给药功能的新型和新兴给药技术和装置,双向给药是一种适用于多种分散技术的新型鼻腔给药概念。